116 related articles for article (PubMed ID: 17401297)
1. The relationship among risk factor clustering, abdominal obesity, and residual risk for cardiovascular events.
Ryan DH
Rev Cardiovasc Med; 2007; 8(1):9-16. PubMed ID: 17401297
[TBL] [Abstract][Full Text] [Related]
2. [The best of epidemiology and cardiovascular prevention in 2006].
Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
[TBL] [Abstract][Full Text] [Related]
3. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.
Chen L; Peeters A; Magliano DJ; Shaw JE; Welborn TA; Wolfe R; Zimmet PZ; Tonkin AM
Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):740-5. PubMed ID: 18043293
[TBL] [Abstract][Full Text] [Related]
4. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
Scholze J; Lilienthal W; Bramlage P
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
[TBL] [Abstract][Full Text] [Related]
5. Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
Blum S; Milman U; Shapira C; Miller-Lotan R; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):e18-20. PubMed ID: 18296583
[No Abstract] [Full Text] [Related]
6. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
Tsang JL; Mendelsohn A; Tan MK; Hackam DG; Leiter LA; Fitchett D; Lin PJ; Grima E; Langer A; Goodman SG;
Am J Cardiol; 2008 Nov; 102(9):1142-5. PubMed ID: 18940280
[TBL] [Abstract][Full Text] [Related]
7. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
Staels B; Maes M; Zambon A
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
[TBL] [Abstract][Full Text] [Related]
8. Medical management of abdominal aortic aneurysm.
Golledge J; Powell JT
Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):267-73. PubMed ID: 17540588
[TBL] [Abstract][Full Text] [Related]
9. Cardiometabolic risk-factor management.
Ker J
Cardiovasc J Afr; 2008; 19(4):222-4. PubMed ID: 18776972
[No Abstract] [Full Text] [Related]
10. Evaluating and treating cardiometabolic risk factors: a case discussion.
Haines ST; Fuke DC; Lender D; Rodgers PT; Sysko SK
Pharmacotherapy; 2006 May; 26(5 Pt 2):32S-41S. PubMed ID: 16637784
[TBL] [Abstract][Full Text] [Related]
11. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
Haffner SM
Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
[TBL] [Abstract][Full Text] [Related]
12. Challenges and strategies in managing cardiometabolic risk.
Repas TB
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
[TBL] [Abstract][Full Text] [Related]
13. Managing cardiometabolic risk: an evolving approach to patient care.
Watson K
Crit Pathw Cardiol; 2007 Mar; 6(1):5-14. PubMed ID: 17667880
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease risk assessment in patients with obstructive sleep apnoea: clinical utility of the Framingham risk equation for initiating statins.
Horwood F; Gruber A; Sithole J; Ali N; Idris I
Diabetes Obes Metab; 2008 Feb; 10(2):181-2. PubMed ID: 17451427
[No Abstract] [Full Text] [Related]
15. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
[TBL] [Abstract][Full Text] [Related]
16. Do current body mass index criteria for obesity surgery reflect cardiovascular risk?
Livingston EH; Chandalia M; Abate N
Surg Obes Relat Dis; 2007; 3(6):577-85. PubMed ID: 17936086
[TBL] [Abstract][Full Text] [Related]
17. The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
Friedewald VE; Ballantyne CM; Davidson MH; Guyton JR; Roberts WC
Am J Cardiol; 2008 Sep; 102(5):559-67. PubMed ID: 18721512
[No Abstract] [Full Text] [Related]
18. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
Després JP; Cartier A; Côté M; Arsenault BJ
Ann Med; 2008; 40(7):514-23. PubMed ID: 18608131
[TBL] [Abstract][Full Text] [Related]
19. [Study on the relationship between obesity and clustering of major risk factors on cardiovascular diseases in the elderly].
Xie WX; Cao WH; Lin J
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):975-8. PubMed ID: 19173875
[TBL] [Abstract][Full Text] [Related]
20. Tracking of cardiometabolic risk factor clustering from childhood to adulthood.
Camhi SM; Katzmarzyk PT
Int J Pediatr Obes; 2010 Apr; 5(2):122-9. PubMed ID: 19593726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
